Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.50 |
| ▸ | GBA1 | P04062 | 1/20 | 0.50 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.41 |
| ▸ | DNMT1 | P26358 | 1/20 | 0.41 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.41 |
| ▸ | MANBA | O00462 | 1/20 | 0.41 |
| ▸ | IDUA | P35475 | 1/20 | 0.41 |
| ▸ | THRB | P10828 | 1/20 | 0.41 |
| ▸ | GUSB | P08236 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | PPARG | P37231 | 4/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.31 |
| ▸ | HBB | P68871 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7151964 | 1.00 | LMNA (0.50) | LMNAGBA1HIF1ADNMT1CTDSP1 | |
| SCHEMBL290301 | 1.00 | LMNA (0.50) | LMNAGBA1HIF1ADNMT1CTDSP1 | |
| SCHEMBL17956707 | 1.00 | LMNA (0.50) | LMNAGBA1HIF1ADNMT1CTDSP1 | |
| SCHEMBL977551 | 1.00 | LMNA (0.50) | LMNAGBA1HIF1ADNMT1CTDSP1 | |
| SCHEMBL15947392 | 1.00 | LMNA (0.50) | LMNAGBA1HIF1ADNMT1CTDSP1 | |
| SCHEMBL12189851 | 1.00 | LMNA (0.50) | LMNAGBA1HIF1ADNMT1CTDSP1 | |
| SCHEMBL15945043 | 1.00 | LMNA (0.50) | LMNAGBA1HIF1ADNMT1CTDSP1 | |
| SCHEMBL12762744 | 1.00 | LMNA (0.50) | LMNAGBA1HIF1ADNMT1CTDSP1 | |
| SCHEMBL9143456 | 0.92 | — | — | |
| SCHEMBL22106635 | 0.92 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7842723-B2 | Ascorbic acid—natural sugar lactone esters for comprehensive skin and scalp care | BIODERM RESEARCH (US) | 2010-11-30 | — | — | US | claimed |
| US-20080287533-A1 | Ascorbic Acid - Natural Sugar Lactone Esters for Comprehensive Skin & Scalp Care | BIODERM RESEARCH (US) | 2008-11-20 | — | — | US | claimed |
| WO-2021013992-A1 | INJECTABLE POLYMER COMPOSITIONS WITH HYALURONIC ACID CROSS-LINKED BY BORONATE ESTERS AND FUNCTIONALISED BY RGD PEPTIDES FOR CELL AND TISSUE ENGINEERING | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2021-01-28 | — | — | WO | disclosed |
| EP-1751302-B1 | ANALYTE SENSORS AND METHODS FOR MAKING AND USING THEM | MEDTRONIC MINIMED INC (US) | 2012-03-28 | — | — | EP | disclosed |
| US-20100030045-A1 | ANALYTE SENSOR APPARATUSES COMPRISING MULTIPLE IMPLANTABLE SENSOR ELEMENTS AND METHODS FOR MAKING AND USING THEM | MEDTRONIC MINIMED, INC. (US) | 2010-02-04 | — | — | US | disclosed |
| US-20080026473-A1 | Analyte sensors and methods for making and using them | CITIBANK, N.A. | 2008-01-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080287533-A1 | Ascorbic Acid - Natural Sugar Lactone Esters for Comprehensive Skin & Scalp Care | GLA, COLGALT1, COL14A1 | LMNA 927/4885GBA1 237/4885HIF1A 1385/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.